Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.3424 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.29454 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.28503 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.27227 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.27971 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.34651 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.28874 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.17496 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.04306 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.28877 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.58595 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.28417 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.29042 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.92955 | 75 |